Insider Selling: Phreesia, Inc. (NYSE:PHR) Director Sells 20,565 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) Director Michael Weintraub sold 20,565 shares of the company's stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $25.04, for a total value of $514,947.60. Following the sale, the director now directly owns 242,827 shares in the company, valued at approximately $6,080,388.08. This represents a 7.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Michael Weintraub also recently made the following trade(s):

• On Monday, December 16th, Michael Weintraub sold 861 shares of Phreesia stock. The stock was sold at an average price of $25.26, for a total transaction of $21,748.86.
• On Monday, December 2nd, Michael Weintraub sold 15,152 shares of Phreesia stock. The shares were sold at an average price of $21.01, for a total transaction of $318,343.52.

Phreesia Price Performance

PHR traded down $0.77 on Tuesday, reaching $24.87. The company had a trading volume of 463,410 shares, compared to its average volume of 450,575. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16. The company has a market capitalization of $1.45 billion, a P/E ratio of -17.46 and a beta of 0.98. The company has a fifty day moving average of $20.53 and a 200-day moving average of $21.84. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.58) earnings per share. As a group, equities research analysts anticipate that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. Royal Bank of Canada reissued a "sector perform" rating and issued a $23.00 target price on shares of Phreesia in a report on Friday, September 27th. Robert W. Baird cut their price target on Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a report on Wednesday, December 11th. Canaccord Genuity Group restated a "buy" rating and set a $34.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial increased their target price on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Finally, JMP Securities reissued a "market outperform" rating and set a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, Phreesia presently has an average rating of "Moderate Buy" and an average price target of $29.33.

Institutional Investors Weigh In On Phreesia

A number of institutional investors and hedge funds have recently bought and sold shares of PHR. International Assets Investment Management LLC boosted its stake in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after acquiring an additional 1,395 shares in the last quarter. nVerses Capital LLC boosted its position in shares of Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company's stock valued at $64,000 after purchasing an additional 1,300 shares during the period. Lombard Odier Asset Management USA Corp purchased a new position in Phreesia in the 2nd quarter worth about $202,000. Point72 DIFC Ltd acquired a new stake in Phreesia during the 2nd quarter worth about $209,000. Finally, XTX Topco Ltd purchased a new stake in shares of Phreesia in the 3rd quarter valued at approximately $247,000. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.